A Phase II Study of NB001 for Acute Migraine Treatment

NCT07577050 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Migraine

Interventions

DRUG: One tablet of NB001 plus three tablets of placebo
DRUG: Two tablets of NB001 plus two tablets of placebo
DRUG: Four tablets of NB001
DRUG: Four tablets of placebo

Sponsor

Chinese PLA General Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]